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Abstract
Background: Dietary polyunsaturated fatty acids (PUFAs), especially n-3 PUFAs, are important for human health. The
intestinal tract, a location that is heavily colonized by microorganisms, is the main organ for absorbing fatty acids.
Methods: The purpose of this study was to analyze the effects of dietary n-3 and n-6 PUFAs on the distribution of
different types of fatty acids and their bioavailability along the gut. Mice were fed for a week with experimental diets
containing high n-3 or high n-6 fatty acid levels. Blood was collected at different time points, and after 7 days the mice
were euthanized and their digestive tract was divided into 17 segments for fatty acids analyses.
Results: We found that supplementing n-3 fatty acids significantly changed the ratio of n-6/n-3 PUFAs, increased the
bioavailability of n-3 PUFAs, and altered fatty acid distribution. In addition, in the n-3 diet group, the absorption of
saturated fatty acids (SFAs) along the gut was found to be inhibited, which was confirmed by feeding the mice with a
diet containing deuterium-labeled palmitic acid and stearic acid.
Conclusion: These results show that a diet rich in n-3 PUFAs can significantly modify the distribution and bioavailability
of fatty acids, and particularly, may block the absorption of SFAs in the mouse gastrointestinal (GI) tract.
Keywords: n-3 PUFA, SFA, Gut, Distribution, Bioavailability, Absorption
Background
Dietary lipids are important for human health, providing
not only caloric energy, but also taking part in vital
cellular functions. High fat consumption and high ratios
of n-6/n-3 polyunsaturated fatty acids (PUFAs) in the
Western diet are associated with an increased incidence
of obesity, diabetes, cardiovascular disease and cancer
[1, 2]. While saturated fatty acids (SFAs) and monounsatu-
rated fatty acids (MUFAs) can be synthesized de novo,
PUFAs must be obtained via dietary intake. A low ratio of
n-6/n-3 PUFAs may be more important than the total
amount of n-3 PUFAs for health benefits [3, 4].
Different dietary fatty acids are incorporated into the
body with different patterns and efficiencies [5]. Many
factors contribute to this difference in lipid response to
the diet. While the genetic background influences
dietary lipid absorption and metabolism [6], evidence
suggest that the gut microenvironment, including its
complicated environment and the gut microbiota, plays
an important role in fat digestion, absorption and
metabolism [7, 8]. Fatty acids are distributed unevenly
along the gut. The bioavailability of fatty acids is associ-
ated with gastrointestinal function, and alterations in
their metabolism may cause mucosal inflammation and
other gastrointestinal troubles [9]. Supplementation of
n-3 PUFAs can improve gut function via interaction with
the gut microbiota [10].
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In this study, we focused on the effects of high and
low ratios of n-3 PUFAs on the distribution of fatty
acids, including SFAs, MUFAs and PUFAs, and analyzed
in detail the resulting modifications of the uptake of n-3
PUFAs along the gut.
Methods
Animals and diets
Six-week-old male C57BL/6 J mice were obtained
from the Shanghai Laboratory Animal Center (Shang-
hai, China). After 1 week of acclimatization with free
access to standard mouse chow (Commercial diet,
17.14% of energy from fat, 5.05 g/100 g) and water,
the mice were randomly divided into three groups (10
mice were used in a group) and fed a high n-3 PUFA
diet (n-6:n-3 ratio = 1:1), a high n-6 PUFA diet (n-6:n-
3 ratio = 40:1) or control diet (n-6:n-3 ratio = 20:1) for
a week. Diets were prepared by the custom animal
diet laboratory of the Animal Resources Program at
Jiangnan University (Additional file 1: Table S1). All 3
diets contained 397 kcal/100 g, 13 g fat/100 g, and
29.2% of energy was from fat, 46.4% from carbohy-
drates, and 24.4% from proteins.
Two deuterium labeled stable isotopes, hexadecanoic-d31
acid (d31-C16:0, 98.9 atom% D, D-2002, lot No. M-363) and
octadecanoic-d35 acid (d35-C18:0, 99.2 atom% D, D-2007,
lot No. M-413-A) which were purchased from C/D/N
Isotopes Inc. (Poínte-Claíre, Quebec, Canada), were added
to experimental diets at a concentration of 0.14 g/100 g dry
weight diet (Additional file 1: Table S1) and fed a new
cohort of mice which were also divided into control, n-6
PUFA and n-3 PUFA diet groups (5 mice in each group).
All animals were maintained in an isolated environ-
ment in barrier cages and fed the assigned special diet
restricted to 10 g/mouse/day. Daily intake of diet of each
cage of mice were recorded and the average dietary
intake of a mouse in 24 h was calculated accordingly, for
details please reference Additional file 1: Table S2.
Animal care and protocols were approved by the Jiangnan
University Animal welfare and Ethics Committee.
Blood and tissue collection
The C57BL/6 J mice were fed their respective experi-
mental diet for 1 h, 3 h, 6 h, 12 h, 24 h, 3 days, and 7
days, at which times approximately 50 μL blood was col-
lected through the retro-orbital vein, snap-frozen in
liquid nitrogen, and stored at −80 °C until analysis. To
avoid overdraw of blood from the mice, each group was
divided into two subgroups. Blood for the 1 h and 6 h
time points were collected from one of the subgroups,
while blood for the 3 h and 12 h time points were col-
lected from another. Blood and intestinal tract were also
collected on day 7 after euthanasia. The small intestine
consists of duodenum, jejunum and ileum and the
proportion is 1:3:2. We divided the small intestine into
12 equal length segments (Intestinal Segment Number:
ISN, ISN 1–12), and the cecum was one segment (ISN
13); the colon, consisting of proximal and distal parts, was
separated into four equal length segments (ISN 14–17).
Segments were numbered 1–17 from the most proximal
to the most distal segment (Additional file 2: Figure S1).
Segments were cut along the center axis and bent nose
forceps were used to gently scrape the luminal contents,
including undigested residue and intestinal mucosa, into
200 μL PBS buffer per segment.
Blood from mice that were intervened with
deuterium-labeled isotopes was taken after the mice
were fed for a week.
Lipid extraction and derivatization
Total FAs were analyzed in food, blood, and gut tissues of
experimental mice. Samples (20 μL or 20 mg) were
extracted using the method of Bligh and Dyer [11], and a
known amount of pentadecanoic acid (Sigma-Aldrich)
and heneicosanoic acid (Sigma-Aldrich) was added as in-
ternal standard. After the extraction, the organic layers
were combined and evaporated under a stream of nitro-
gen at 30 °C then dissolved in 1 mL of ethanol. Sample
preparation was based on the method of Metcalfe et al.
[12] as described previously [13]. Samples in ethanol were
treated with 0.1 mL of 50% aqueous KOH, tubes were
purged with nitrogen, and then heated to 75 °C for 1 h.
After cooling, nonsaponifiable lipids were removed by ex-
traction with 3 mL of hexane. The aqueous layer was acid-
ified and extracted with 3 mL of hexane, and the hexane
layer was removed and dried under a stream of nitrogen.
The residue was treated with 0.5 M methanolic NaOH at
100 °C for 5 min. After cooling, samples were treated with
1 mL of 14% BF3 in methanol (Sigma-Aldrich), flushed
with Ar, and then heated to 100 °C for 5 min. After cool-
ing, samples were treated with 4 mL of hexane and 4 mL
of saturated, aqueous NaCl, and the hexane layer was
transferred to a new tube, dried under a stream of nitro-
gen, then dissolved with hexane (200 μL for blood samples
or 1000 μL for tissue samples).
GC/MS analysis
Fatty acids analyses were performed on GCMS-QP2010
Ultra (Shimadzu Co., Tokyo, Japan) with a Rtx-Wax
column (0.25 mm× 30 m, 0.25 μm) (Restek International,
Bellefonte, PA, USA). The column oven was initially kept
at 40 °C for 5 min, and then the temperature was raised to
120 °C and 190 °C sequentially at a rate of 20 °C/min and
5 °C/min respectively. Oven temperature was kept at 190 °C
for 5 min and then ramped to 220 °C at a rate of 5 °C/min
and kept for 17 min. Helium was used as the carrier gas
with a constant linear velocity of 0.94 mL/min.
Temperature of GC inject, EI ion source and the interface
Yang et al. Lipids in Health and Disease  (2017) 16:10 Page 2 of 8
were set at 240 °C, 220 °C and 250 °C, respectively. Full scan
of m/z 50-550 was started at 3.0 min. Sample injection vol-
ume was 1.0 μL and the split ratio was 10.
Statistics and multivariate data analysis
One-way Analysis of Variance (ANOVA) (SPSS 20.0,
Chicago, IL, USA) was conducted to detect any differ-
ences between groups (Ctrl, n-3 PUFA and n-6 PUFA
diet). Those variables (FA) with a p -value less than 0.05
were considered significant.
Multivariate data analysis was conducted by SIMCA-P
+ software (Ver. 11, Umetrics, Umeå, Sweden). PCA
(principal component analysis) biplot which shows both
the scores and loadings was used to demonstrate the re-
lationship between samples and the FA species.
Results
PUFA composition in blood responded swiftly and
efficiently to dietary fat intake
To address the animal response to high and low ratios of
n-6/n-3 PUFAs in the diet, we fed mice with synthetic di-
ets containing different fatty acid compositions. The diets,
including control, high n-3 and high n-6 diets, were nutri-
tionally balanced with equal caloric input and total fatty
acid amounts. Experimental diets with different amount
of n-3 and n-6 PUFAs were prepared based on the desired
n-6/n-3 PUFA ratios and verified by GC/MS analysis
(Additional file 1: Table S1). There was no significant dif-
ference in daily food intake among the groups.
Fatty acid composition in the whole blood was ana-
lyzed at different time points after feeding mice with the
experimental diets. As seen in Fig. 1, PUFA composition
in mice whole blood, including n-3 PUFAs and n-6
PUFAs, was altered 3 h after dietary intake. After 7 days,
the levels of n-3 PUFAs increased from 7.23 to 17.16%
and the levels of n-6 PUFAs decreased from 28.81 to
18.69% in the n-3 diet group. When mice were fed with
the n-6 diet, the levels of n-3 PUFAs in mice blood de-
creased from 7.23 to 3.99% and the levels of n-6 PUFAs
increased from 28.81 to 35.59% (Fig. 1). Total levels of
PUFAs, MUFAs and SFAs were similar to the fatty acid
composition of the respective diets (Additional file 1:
Table S1). These data clearly show that blood FA levels
in mice responded to the high n-3 and n-6 PUFAs diets
quickly and efficiently and reflected in part the fatty acid
absorption in the intestinal tract. The blood lipid com-
position also reflected the dietary fatty acid content.
Dietary intake of PUFAs modified the n-6/n-3 PUFA ratio
and bioavailability
We measured the n-3 and n-6 PUFA in each segment,
and the results suggest that the n-3 diet can significantly
Fig. 1 Composition of polyunsaturated fatty acids (PUFAs), n-3 PUFAs and n-6 PUFAs in blood. Polyunsaturated fatty acids (PUFAs), n-3 PUFAs
and n-6 PUFAs are shown as a percentage of total FAs. a, d, g Blood PUFAs of the control, n-3 and n-6 PUFA groups. b, e, h: n-3 PUFAs of the
three groups. c, f, i: n-6 PUFAs of the three groups
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increase the bioavailability of n-3 PUFAs in the whole
gut. In the n-3 group, the n-3 and n-6 PUFAs decreased
along the GI tract from the anterior to posterior seg-
ments, dropping from 16.27 and 21.8 to 5.09 and 8.22%,
respectively. Meanwhile, in the n-6 group, the n-3 and
n-6 PUFAs decreased from 1.94 and 49.69% to 0.49 and
24.25%, respectively (Table 1). The n-6/n-3 PUFA ratios
along the gut was altered correspondingly, ranging from
1.25 to 3.03 (n-3 diet) and 15.10-32.53 (n-6 diet)
(Table 2). This indicates that, compared to its n-6 coun-
terpart, n-3 PUFAs might have a more significant effect
on the bioavailability of FAs along the gut as well as the
n-6/n-3 PUFA ratio.
The total content of PUFA, MUFA and SFA along the
gut was determined and is shown in Table 3. We found
that total PUFA levels decreased, while total MUFA
levels increased along the intestinal tract in both n-3
and n-6 diet groups. However, the SFAs levels in the n-3
diet group were higher than in the other two groups,
especially in the last two segments. This data hinted that
the absorption of SFA was disturbed by the presence of
n-3 PUFAs in the gut.
To further investigate this possibility, diets supple-
mented with deuterium-labeled FAs (d31-C16:0, d35-
C18:0) were used to feed the mice. Results (Fig. 2)
indicate that SFAs accumulation was comparable in the
n-6 PUFA and control groups, and decreased in the n-3
PUFA group. One-way ANOVA analysis has shown that
Table 1 n-3 polyunsaturated fatty acids (PUFAs) and n-6 PUFAs content (in% of total FA) of the 17 intestinal segments
ISN Control group n-3 group n-6 group
n-3 PUFAs n-6 PUFAs n-3 PUFAs n-6 PUFAs n-3 PUFAs n-6 PUFAs
1 2.68 ± 0.34 30.56 ± 0.84 16.27 ± 1.10 21.83 ± 1.83 1.94 ± 0.66 49.60 ± 1.14
2 2.42 ± 0.25 28.30 ± 1.86 15.84 ± 1.61 20.21 ± 1.51 1.38 ± 0.42 48.51 ± 6.60
3 1.90 ± 0.48 25.68 ± 7.88 14.06 ± 2.39 19.56 ± 1.73 1.17 ± 0.18 49.69 ± 2.82
4 2.38 ± 0.42 29.54 ± 5.54 15.82 ± 2.02 20.41 ± 2.91 1.13 ± 0.40 46.98 ± 5.08
5 2.09 ± 0.76 26.38 ± 7.62 15.67 ± 1.71 19.50 ± 2.32 1.00 ± 0.45 39.51 ± 5.79
6 2.77 ± 0.16 27.65 ± 7.21 13.24 ± 3.65 17.49 ± 2.28 1.53 ± 0.62 43.92 ± 9.39
7 1.76 ± 0.33 19.35 ± 1.95 13.52 ± 2.78 18.31 ± 1.76 1.79 ± 0.74 39.39 ± 5.11
8 2.14 ± 0.76 21.46 ± 5.63 6.10 ± 2.73 15.93 ± 2.53 1.92 ± 1.14 34.37 ± 8.04
9 2.79 ± 1.99 23.94 ± 10.2 5.90 ± 2.24 15.13 ± 2.37 3.06 ± 0.76 35.52 ± 5.08
10 1.76 ± 0.87 17.13 ± 5.65 12.80 ± 5.75 18.03 ± 2.52 1.98 ± 1.21 36.48 ± 7.75
11 2.81 ± 1.27 18.91 ± 5.84 13.13 ± 2.90 16.45 ± 1.99 0.81 ± 0.10 29.23 ± 3.69
12 1.14 ± 0.36 12.77 ± 2.28 9.38 ± 3.98 15.10 ± 2.99 0.67 ± 0.05 30.22 ± 4.86
13 1.98 ± 0.86 13.51 ± 2.33 5.62 ± 1.49 14.49 ± 3.80 1.31 ± 0.18 26.16 ± 1.50
14 1.76 ± 0.86 15.34 ± 2.18 5.76 ± 0.77 16.51 ± 3.77 0.49 ± 0.09 30.98 ± 1.97
15 2.25 ± 1.50 14.83 ± 4.98 5.09 ± 2.18 19.14 ± 3.44 1.17 ± 0.26 27.79 ± 2.63
16 2.83 ± 0.03 11.36 ± 1.44 7.56 ± 1.51 8.22 ± 2.36 0.71 ± 0.33 25.94 ± 2.35
17 2.34 ± 0.09 10.51 ± 2.77 5.38 ± 1.56 10.70 ± 4.96 0.81 ± 0.16 24.25 ± 2.29
Values are x  s, as for n-3 PUFA3, there were no significance between Control and n-6 groups (P > 0.05 by ANOVA); and there were significant differences between
n-3 and Control or n-6 groups (P < 0.05 by ANOVA) for n-3 PUFAs, as well as among Control, n-3 and n-6 groups (P < 0.05 by ANOVA) for n-6 PUFAs
Table 2 Ratios of n-6 polyunsaturated fatty acids (PUFAs) to n-3
PUFAs in the intestinal segments
ISN Control group n-3 group n-6 group
1 11.67 ± 1.19 1.34 ± 0.07 29.07 ± 2.24
2 12.18 ± 1.25 1.28 ± 0.03 30.19 ± 2.55
3 12.66 ± 1.43 1.41 ± 0.20 32.53 ± 2.53
4 12.89 ± 0.53 1.30 ± 0.14 32.05 ± 1.80
5 12.46 ± 0.99 1.25 ± 0.09 31.48 ± 2.50
6 11.50 ± 1.46 1.35 ± 0.16 26.77 ± 2.82
7 11.48 ± 1.30 1.39 ± 0.14 22.83 ± 2.46
8 10.73 ± 1.42 2.70 ± 0.52 20.22 ± 1.69
9 11.51 ± 1.30 2.73 ± 0.30 15.10 ± 1.92
10 10.65 ± 1.25 1.73 ± 0.06 25.13 ± 1.65
11 9.97 ± 1.26 1.32 ± 0.26 26.72 ± 1.59
12 11.61 ± 1.11 1.83 ± 0.26 30.98 ± 1.24
13 10.35 ± 1.53 2.68 ± 0.25 26.64 ± 1.63
14 10.83 ± 1.82 2.88 ± 0.35 25.11 ± 1.96
15 11.35 ± 1.10 3.03 ± 0.34 22.07 ± 1.49
16 10.36 ± 0.47 2.23 ± 0.37 25.13 ± 1.43
17 11.90 ± 1.15 2.23 ± 0.09 31.13 ± 1.28
Values are x  s, differences of ratios of n-6 PUFAs to n-3 PUFAs in all
the intestinal segments were significant among Control, n-3 and n-6 groups (P< 0.05
by ANOVA)
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Table 3 Polyunsaturated fatty acid, monounsaturated fatty acid, saturated fatty acid content (in % of total FA) of the 17 intestinal segments
ISN PUFAs (%) MUFAs (%) SFAs (%)
Control diet n-3 diet n-6 diet Control diet n-3 diet n-6 diet Control diet n-3 diet n-6 diet
1 33.2 ± 1.0 38.1 ± 2.8 51.5 ± 0.6 32.3 ± 2.4 23.2 ± 5.5 16.7 ± 2.0 31.9 ± 2.1 37.1 ± 4.6 29.8 ± 1.8
2 30.7 ± 1.7 36.1 ± 3.1 49.9 ± 6.5 35.4 ± 3.5 24.3 ± 6.8 19.3 ± 4.1 31.5 ± 3.2 37.9 ± 4.9 28.8 ± 3.5
3 27.6 ± 8.4 33.6 ± 3.8 50.9 ± 2.8 39.8 ± 8.4 29.5 ± 4.8 22.2 ± 5.2 30.2 ± 0.3 35.0 ± 2.2 25.3 ± 3.3
4 31.9 ± 5.9 36.2 ± 4.6 48.1 ± 5.4 32.3 ± 5.3 26.6 ± 5.4 22.9 ± 8.8 33.3 ± 2.9 35.2 ± 2.3 27.3 ± 4.1
5 28.5 ± 8.4 35.2 ± 3.9 40.5 ± 6.0 38.0 ± 10.6 26.1 ± 6.8 30.6 ± 6.3 30.5 ± 2.5 36.8 ± 3.8 27.0 ± 4.2
6 30.4 ± 7.3 30.7 ± 5.9 40.6 ± 3.2 32.9 ± 9.9 28.5 ± 7.9 20.4 ± 12.6 33.3 ± 3.2 38.8 ± 4.1 31.8 ± 8.2
7 21.1 ± 2.1 31.8 ± 4.5 41.2 ± 5.6 47.1 ± 5.3 26.7 ± 4.9 24.0 ± 6.9 29.3 ± 3.3 39.4 ± 1.7 32.2 ± 6.0
8 23.6 ± 6.2 22.0 ± 4.9 36.3 ± 9.1 41.8 ± 9.6 41.1 ± 8.5 25.2 ± 11.2 31.6 ± 2.8 35.2 ± 4.0 35.5 ± 1.6
9 26.7 ± 12.2 21.0 ± 3.4 38.6 ± 5.8 36.8 ± 18.6 42.0 ± 4.7 18.5 ± 5.6 33.1 ± 5.5 35.4 ± 2.0 38.4 ± 3.4
10 18.9 ± 6.5 30.8 ± 8.1 38.5 ± 8.1 51.0 ± 10.9 27.5 ± 11.7 25.7 ± 8.1 27.6 ± 5.5 39.0 ± 2.8 32.1 ± 5.6
11 21.7 ± 7.1 29.6 ± 4.0 30.0 ± 3.8 42.4 ± 4.5 24.7 ± 7.2 39.6 ± 3.9 32.4 ± 4.3 43.7 ± 4.6 28.2 ± 6.0
12 13.9 ± 2.6 24.5 ± 5.9 30.9 ± 4.8 55.5 ± 4.4 33.3 ± 8.9 36.9 ± 2.5 28.8 ± 3.0 40.7 ± 8.3 30.2 ± 3.8
13 15.5 ± 1.6 20.1 ± 2.8 27.5 ± 1.5 48.5 ± 7.1 44.1 ± 4.8 35.9 ± 3.0 32.9 ± 7.9 33.7 ± 7.1 33.6 ± 4.0
14 17.1 ± 2.0 22.3 ± 3.5 31.5 ± 2.0 41.0 ± 11.2 38.1 ± 5.5 40.3 ± 2.2 40.3 ± 13.4 38.2 ± 9.0 26.0 ± 2.5
15 16.5 ± 3.6 24.2 ± 1.7 29.0 ± 2.9 42.2 ± 12.7 42.9 ± 4.4 32.1 ± 1.6 38.8 ± 13.0 31.3 ± 5.7 35.5 ± 3.6
16 12.8 ± 2.7 15.8 ± 3.2 25.6 ± 1.2 35.3 ± 7.8 24.7 ± 6.7 32.9 ± 1.0 48.2 ± 10.0 57.4 ± 10.0 38.9 ± 2.3
17 11.7 ± 4.0 16.1 ± 5.0 24.8 ± 2.8 33.4 ± 4.9 30.8 ± 10.5 33.3 ± 3.2 50.7 ± 10.6 51.5 ± 15.5 39.5 ± 6.6
Values are x  s
Fig. 2 Accumulation of deuterium-labeled C16:0 (d31 C16:0) and C18:0 (d35 C18:0) in blood. Exogenous d31-C16:0 and d35-C18:0 in the blood on
day 7 are shown in relative amount (as a percentage of the total blood fatty acids) (a) and in absolute amount (b) among control, n-3 and n-6
polyunsaturated fatty acid groups. One-way ANOVA analysis was performed by SPSS (IBM SPSS Statistics, Ver. 20) and those were of significance
(P < 0.05) were marked with an asterisk (N = 5)
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the change of d35-C18:0 were of significance (P < 0.05)
between n-3 and control or n-6 groups. However, as for
d31-C16:0, its change among the groups were of no
significance. Possible reason for this might be that the
exogenous d31-C16:0 were transformed to stearic acid
[14] thus. This theory was validated by the facts that
though almost equal amounts of d31-C16:0 and d35-
C18:0 were added in the diets, the detected d31-C16:0
was half of that of d35-C18:0 (Fig. 2) and d31-C18:0 was
detected from the mice blood (Additional file 3: Figure
S2). These data suggest the dietary intake of high n-3 or
n-6 PUFAs had different effects on the absorption of
SFAs in the mouse gut.
n-3 PUFAs influence the distribution of fatty acids in the
gut
A principal component analysis (PCA) was performed
on intestinal FA data of n-3 and n-6 groups to
further characterize the relationships between fatty
acid species or classes and intestinal position or the
intestinal environment, respectively. Segments which
are clustered together have a similar fatty acid com-
position. In the loadings biplot (Fig. 3a and b), the
n-3 group segments clustered well according to their
position in the intestinal tract, whereas the n-6 group
segments were scattered.
In n-3 group, the anterior end of the small intestine,
including the duodenum, the major segments of the je-
junum and ileum (ISN 1-7 and 10-12), with the
exception of segments 8 and 9, were clustered as their
PUFA composition consisted mainly of EPA (eicosa-
pentaenoic acid, C20:5), DHA (docosahexaenoic acid,
C22:6), LA (linoleic acid, C18:2) and AA (arachidonic
acid, C20:4). And in more distal segments of the intes-
tinal tract, the caecum and the proximal colon (ISN 13-
15), the principal FAs were MUFAs (hexadecenoic acid,
C16:1; octadecenoic acid, C18:1), whereas in the poster-
ior end, mainly the distal colon (ISN 16-17), segments
were clustered and closer to the SFAs (myristic acid,
C14:0, palmitic acid, C16:0, eicosanoic acid C20:0, doco-
sanoic acid, C22:0) (Fig. 3a and b). This could be a direct
reflection of the absorption of different FAs along the
gut, where dietary n-3 PUFA intake could induce differ-
ential absorption of PUFAs, MUFAs and SFAs. These
data further indicate that dietary supplementation of n-3
PUFAs can enrich their bioavailability and modify the
distribution of other fatty acids along the gut.
Discussion
Epidemiological studies suggest that the consumption of
n-PUFAs is beneficial for our health, and nutritionists
often advise their patients to lower the n-6/n-3 fatty acid
ratio in their diets [15]. To better understand the benefi-
cial effects of a lower ratio of n-6/n-3 PUFAs, this study
investigated the effects of different n-6/n-3 ratios on the
organism by characterizing the FA composition along
the intestinal tract and in the blood of C57BL/6J mice.
Data showed that changing the n-6/n-3 PUFAs ratio in
Fig. 3 Principal component analysis (PCA) loadings biplot of intestinal fatty acids. a Biplot PCA of n-3 group, PC1 = 51.5%, PC2 = 31.7%; b biplot
PCA of n-6 group, PC1 = 50.2%, PC2 = 23.7%. Black triangles: fatty acids; red squares: intestinal segments
Yang et al. Lipids in Health and Disease  (2017) 16:10 Page 6 of 8
the diet could effectively alter n-6/n-3 PUFA ratios and
the FA absorption along the gut.
Factors such as pH of the intestinal tract, bile acid
secretion and microorganisms introduce drastic environ-
mental change along the gut, and this might affect the
absorption of dietary nutrients, including the FAs which
are the focus of this work. As for fatty acids, there might
be other factor such as fatty acid trasport proteins which
effects their abosption. In a recent review of fatty acid
transport proteins, Gomeno [16] stated that the new
functions of these proteins are beening found, and they
can also mediate the uptake of fatty acids. To interpret
possible effects of n-3 and/or n-6 PUFA on the bioavail-
ability and distribution of various FAs along the gut,
mice were fed with experimental control, n-3 and n-6
PUFA diets for 7 days and were euthanized. The guts
were taken and each was divided into 17 segments
(Additional file 2: Figure S1) for fatty acid analysis.
The quantity of total FAs in a given gut segment
varied dramatically in individual mice, which may be
related to the movement of the bowel along the gut.
However, the percentage of each fatty acid was con-
sistent. We therefore used the percentage to represent
fatty acid content in each segment. Our data showed
that the PUFA levels gradually decrease along the gut,
from proximal to distal segments, which is consistent
with the fact that the small intestine is the main
organ where fatty acids are absorbed (Table 3).
Through the progress of fatty acid absorption, the
percentage of MUFAs along the gut became higher,
while the SFA levels were steady, except in the last
two segments. This phenomenon was particularly ob-
vious when mice were fed with the high n-3 diet
(Table 3). These data suggest that PUFAs could slow
or prevent the absorption of SFAs, and n-3 PUFAs
have a stronger effect than n-6 PUFAs.
Many factors could influence the absorption efficiency
of fatty acids in the intestinal tract. Radiolabeled or stable
isotopic fatty acid tracers, easily distinguishable from
endogenic fatty acids, have be used to determine the ab-
sorption, digestion and interaction among the fatty acids
in the neonatal piglets [17]. By feeding mice with diets
mixed with deuterium-labeled SFAs, we have shown that
the blood level of labeled SFAs declined significantly in
n-3 diet group compared to the other two groups. These
data are also consistent with the fact that SFAs were
higher in the mouse gut in the n-3 diet group. These find-
ings lead us to hypothesize that n-3 PUFAs can inhibit the
absorption of saturated fatty acids in the mouse gut,
through a mechanism that remains to be identified.
PCA biplots were constructed to visualize graphically
the correlation between fatty acid species and intestinal
position, as shown in Fig. 3. The results show that, after
supplementation with n-3 PUFAs, segments along the
whole gut were mainly clustered into 3 discrete sections,
based on their enrichment in specific FA species: small
intestinal segments (mainly PUFAs), caecum and prox-
imal colon segments (mainly MUFAs) and distal colon
segments (mainly SFAs). Unlike the majority of intestinal
segments (1-7 and 10-12), intestinal segments 8 and 9
were closely clustered with segments of the caecum and
proximal colon. It is not clear whether the very low total
fatty acid contents in these two segments led to their
deviation in the PCA biplot. Nonetheless, the results
overall suggest that the uptake of fatty acid in the gut
may occur in the order of PUFAs, MUFAs and SFAs,
and n-3 PUFAs diets might enhance the differences in
absorption efficiency of these different FAs (Fig. 3a). In
the n-3 PUFA group, even though the FA analysis in the
GI tract demonstrated reduced absorption of SFAs, a
resulting decline of SFA levels in the blood was not ob-
served. To test the possibility that this might due to a
compensation of the de novo synthesis of SFAs in the
mice, diets containing deuterium-labeled palmitic acid
and stearic acid were used to feed the mice. Results from
the stable isotope experiments confirm a decline in the
assimilation of exogenous d31-C16:0 and d35-C18:0 in
the blood of mice from n-3 PUFA diet group.
Various effects of PUFA, either n-3 or n-6 PUFA have
been investigated [4, 18]. Undurti et al [10] studied the
effect of fish oil with a high content of n-3 PUFA on
mouse gut microbiota, and found that the fish oil treat-
ment could change the gut microbiota. They proposed
that this might be the potential mechanism of how n-3
PUFAs exert their biological effects. However, the spe-
cific mechanism may differ in different cases. Raghu et
al reported the inhibition of intestinal β-carotene uptake
by eicosapentaenoic acid (EPA) in their recent work
[19]. They studied the effect of docosahexaenoic acid
(DHA) and EPA on the absorption of β-carotene in in-
testinal cells and animal models. Their results shown
that by down regulation of the scavenger receptor class
B, type 1 via PPARα dependent mechanism, EPA and
PPARα agonist could inhibit the uptake of β-carotene in
Caco-2/TC7 cells. However, for DHA, PPARγ or PPARδ
agonists, there were no such effect. This work indicated
that other lipids maybe effected by n-3 PUFA in a simi-
lar way. Besides, it also shown that different species of
n-3 PUFA may have different effects.
In our study, we systematically investigated the influ-
ence of dietary n-3 and n-6 PUFA intake on the distribu-
tion and bioavailability of fatty acids along the whole
mouse gut. This study was made possible by using nutri-
tionally balanced experimental diets with equal total
fatty acid inputs, since the concentration of fat in the
diet may influence the absorption of fatty acids [20]. Our
results show that n-3 and n-6 PUFA composition in
mice blood responded efficiently to experimental diets
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as early as 3 h after feeding, and reflected the dietary
fatty acid input accurately. Gut fatty acid analysis
revealed that an n-3 PUFA-rich diet can decrease the
ratio of n-6/n-3 PUFAs along the gut and increase the
bioavailability of n-3 PUFAs in the whole gut. Further-
more, by feeding the mice with diets containing isotope-
labeled SFAs (d31-C16:0, d35-C18:0), we found that n-3
PUFA supplementation can reduce the absorption of
saturated fatty acids in the gut. To our knowledge, this
is the first report of this phenomenon.
Conclusion
In the present work, we analyzed the distribution of
blood and intestinal fatty acids of mice that were fed
with home-made high n-3 and high n-6 fatty acid diets.
The results indicated that supplements of n-3 fatty acids
could increase the bioavailability of n-3 PUFAs, thus
changed the ratio of n-6/n-3 PUFAs and altered fatty
acid distribution. Besides, in the n-3 diet group, the
absorption of saturated fatty acids (SFAs) along the gut
was found to be inhibited and confirmed by feeding the
mice with a diet containing deuterium-labeled palmitic
acid and stearic acid.
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